ScholarIQanswers from OpenAlex & ORCID
Judith Balmañà
ResearcherPublications, citations & collaboration network
Judith Balmañà is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Judith Balmañà have?
ScholarIQindexed works
Judith Balmañà has 619 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Judith Balmañà have?
ScholarIQcitation count
Judith Balmañà has 19,620 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Judith Balmañà?
ScholarIQh-index
Judith Balmañà has an h-index of 66 in OpenAlex.
What is the i10-index of Judith Balmañà?
ScholarIQi10-index
Judith Balmañà has an i10-index of 187 in OpenAlex.
What is the ORCID of Judith Balmañà?
ScholarIQorcid
The ORCID for Judith Balmañà is on the source record.
What is the OpenAlex record for Judith Balmañà?
ScholarIQopenalex
The OpenAlex for Judith Balmañà is on the source record.
What are the most-cited papers on Judith Balmañà?
ScholarIQmost cited works
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation
Bella Kaufman, Ronnie Shapira‐Frommer, Rita K. Schmutzler, M. William Audeh, Michael Friedländer, Judith Balmañà, Gillian Mitchell, Georgeta Fried, Salomon M. Stemmer, Ayala Hubert, Ora Rosengarten, Mariana Steiner, Niklas Loman, Karin Bowen, Anitra Fielding, Susan M. Domchek
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
Catherine M. Phelan, Karoline Kuchenbaecker, Jonathan P. Tyrer, Siddhartha Kar, Kate Lawrenson, Stacey J. Winham, Joe Dennis, Ailith Pirie, Marjorie J. Riggan, Ganna Chornokur, Madalene A. Earp, Paulo C. Lyra, Janet M. Lee, Simon G. Coetzee, Jonathan Beesley, Lesley McGuffog, Penny Soucy, Ed Dicks, Andrew Lee, Daniel Barrowdale, Julie Lecarpentier, Goska Leslie, Cora M. Aalfs, Katja K.H. Aben, Marcia Adams, Julian Adlard, Irene L. Andrulis, Hoda Anton‐Culver, Natalia Antonenkova, AOCS study group, Gerasimos Aravantinos, Norbert Arnold, Banu Arun, Brita Arver, Jacopo Azzollini, Judith Balmañà, Susana Banerjee, Laure Barjhoux, Rósa B. Barkardóttir, Yukie T. Bean, Matthias W Beckmann, Alicia Beeghly-Fadiel, Javier Benı́tez, Marina Bermisheva, Marcus Q. Bernardini, Michael J. Birrer, Line Bjorge, Amanda Black, Kenneth B. Blankstein, Marinus J. Blok, Clara Bodelón, Natalia Bogdanova, Anders Bojesen, Bernardo Bonanni, Åke Borg, Angela R. Bradbury, James D. Brenton, Carole Brewer, Louise A. Brinton, Per Broberg, Angela Brooks‐Wilson, Fiona Bruinsma, Joan Brunet, Bruno Buecher, Ralf Butzow, Saundra S. Buys, Trinidad Caldés, Maria A. Caligo, Ian Campbell, Rikki Cannioto, Michael E. Carney, Terence Cescon, Salina B Chan, Jenny Chang-Claude, Stephen J. Chanock, Xiao Qing Chen, Yoke-Eng Chiew, Jocelyne Chiquette, Wendy K. Chung, Kathleen Claes, Thomas Conner, Linda S. Cook, Jackie Cook, Daniel W. Cramer, Julie M. Cunningham, Aimee A. D’Aloisio, Mary B Daly, Francesca Damiola, Sakaeva Dina Damirovna, Agnieszka Dansonka‐Mieszkowska, Fanny Dao, Rosemarie Davidson, Anna DeFazio, Capucine Delnatte, Kimberly F. Doheny, Orland Dı́ez, Yuan Chun Ding, Jennifer A. Doherty, Susan M. Domchek, Cecilia M. Dorfling
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
ABCTB Investigators, Roger L. Milne, EMBRACE, GEMO Study Collaborators, HEBON, kConFab/AOCS Investigators, NBSC Collaborators, Karoline Kuchenbaecker, Kyriaki Michailidou, Jonathan Beesley, Siddhartha Kar, Sara Lindström, Shirley Hui, Audrey Lemaçon, Penny Soucy, Joe Dennis, Xia Jiang, Asha Rostamianfar, Hilary K. Finucane, Manjeet K. Bolla, Lesley McGuffog, Qin Wang, Cora M. Aalfs, Marcia Adams, Julian Adlard, Simona Agata, Shahana Ahmed, Habibul Ahsan, Kristiina Aittomäki, Fares Al‐Ejeh, Jamie Allen, Christine B. Ambrosone, Christopher I. Amos, Irene L. Andrulis, Hoda Anton‐Culver, Natalia Antonenkova, Volker Arndt, Norbert Arnold, Kristan J. Aronson, Bernd Auber, Paul L. Auer, Margreet G.E.M. Ausems, Jacopo Azzollini, François Bacot, Judith Balmañà, Monica Barile, Laure Barjhoux, Rósa B. Barkardóttir, Myrto Barrdahl, Daniel R. Barnes, Daniel Barrowdale, Caroline Baynes, Matthias W. Beckmann, Javier Benı́tez, Marina Bermisheva, Leslie Bernstein, Yves‐Jean Bignon, Kathleen R. Blazer, Marinus J. Blok, Carl Blomqvist, William J. Blot, Kristie Bobolis, Bram Boeckx, Natalia Bogdanova, Anders Bojesen, Stig E. Bojesen, Bernardo Bonanni, Anne‐Lise Børresen‐Dale, Anikó Bozsik, Angela R. Bradbury, Judith S. Brand, Hiltrud Brauch, Hermann Brenner, Brigitte Bressac–de Paillerets, Carole Brewer, Louise A. Brinton, Per Broberg, Angela Brooks‐Wilson, Joan Brunet, Thomas Brüning, Barbara Burwinkel, Saundra S. Buys, Jinyoung Byun, Qiuyin Cai, Trinidad Caldés, Maria A. Caligo, Ian Campbell, Federico Canzian, Olivier Caron, Ãngel Carracedo, Brian D. Carter, Jose E. Castelao, Laurent Castéra, Virginie Caux‐Moncoutier, Salina Chan, Jenny Chang‐Claude, Stephen J. Chanock, Xiaoqing Chen, Ting‐Yuan David Cheng, Jocelyne Chiquette
Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk
Fergus J. Couch, Xianshu Wang, Lesley McGuffog, Andrew Lee, Curtis Olswold, Karoline B. Kuchenbaecker, Penny Soucy, Zachary Fredericksen, Daniel Barrowdale, Joe Dennis, Mia M. Gaudet, Ed Dicks, Matthew Kosel, Sue Healey, Olga M. Sinilnikova, Adam F. Lee, François Bacot, Daniel Vincent, Frans B. L. Hogervorst, Susan Peock, D Stoppa-Lyonnet, Anna Jakubowska, kConFab Investigators, Paolo Radice, Rita Katharina Schmutzler, SWE-BRCA, Susan M. Domchek, Marion Piedmonte, Christian F. Singer, Eitan Friedman, Mads Thomassen, Ontario Cancer Genetics Network, Thomas van Overeem Hansen, Susan L. Neuhausen, Csilla I. Szabo, Ignacio Blanco, Mark H. Greene, Beth Karlan, Judy E. Garber, Catherine M. Phelan, Jeffrey N. Weitzel, Marco Montagna, Edith Olah, Irene L. Andrulis, Andrew K. Godwin, Drakoulis Yannoukakos, David E. Goldgar, Trinidad Caldés, Heli Nevanlinna, Ana Osório, Mary Beth Terry, Mary B. Daly, Elizabeth J. van Rensburg, U. Hamann, Susan J. Ramus, Amanda Ewart Toland, Maria A. Caligo, Olufunmilayo I. Olopade, Nadine Tung, Kathleen Claes, Mary Beattie, Melissa C. Southey, Evgeny N. Imyanitov, Marc Tischkowitz, Ramūnas Janavičius, Esther M. John, Ava Kwong, Orland Dı́ez, Judith Balmañà, Rósa B. Barkardóttir, Banu Arun, Gad Rennert, Soo‐Hwang Teo, Patricia A. Ganz, Ian Campbell, Annemarie H. van der Hout, Carolien H. M. van Deurzen, Caroline Seynaeve, E. Gómez, Flora E. van Leeuwen, Hanne Meijers‐Heijboer, Johannes J. P. Gille, Margreet G. E. M. Ausems, Marinus J. Blok, Marjolijn J. L. Ligtenberg, Matti A. Rookus, Peter Devilee, Senno Verhoef, Theo A.M. van Os, Juul T. Wijnen, HEBON, EMBRACE, Debra Frost, Steve Ellis, Elena Fineberg, Radka Platte, D. Gareth Evans, Louise Izatt, Rosalind A. Eeles, Julian Adlard
A Phase I–II Study of the Oral PARP Inhibitor Rucaparib in Patients with Germline <i>BRCA1/2</i> -Mutated Ovarian Carcinoma or Other Solid Tumors
Rebecca Kristeleit, Geoffrey I. Shapiro, Howard A. Burris, Amit M. Oza, Patricia LoRusso, Manish R. Patel, Susan M. Domchek, Judith Balmañà, Yvette Drew, Lee-may Chen, Tamar Safra, Ana Fernández Montés, Heidi Giordano, Lara Maloney, Sandra Goble, Jeff Isaacson, Jim Xiao, Jen Borrow, Lindsey Rolfe, Ronnie Shapira‐Frommer